A Brief Overview of GLP-1 Agonists: A Primer for Stroke Clinicians

Abstract

                The use of GLP-1 agonists very common for treatment of diabetes and weight management. The purpose of this review is to provide background information on the mechanism of how GLP-1 agonists work along with the different considerations for patients who may be on GLP-1 therapy. The paper will also briefly review the literature on the impact GLP-1 agonists have on diabetes and major adverse cardiovascular events, including stroke. Lastly, the review will provide some guidance on the management of patients who may present to the hospital with a stroke on GLP-1 agonist therapy.